BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33190136)

  • 21. Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging.
    De Robertis R; D'Onofrio M; Zamboni G; Tinazzi Martini P; Gobbo S; Capelli P; Butturini G; Girelli R; Ortolani S; Cingarlini S; Pederzoli P; Scarpa A
    Neuroendocrinology; 2016; 103(6):758-70. PubMed ID: 26646652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?
    De Robertis R; Maris B; Cardobi N; Tinazzi Martini P; Gobbo S; Capelli P; Ortolani S; Cingarlini S; Paiella S; Landoni L; Butturini G; Regi P; Scarpa A; Tortora G; D'Onofrio M
    Eur Radiol; 2018 Jun; 28(6):2582-2591. PubMed ID: 29352378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors?
    Kann PH
    Rev Endocr Metab Disord; 2018 Jun; 19(2):133-137. PubMed ID: 30267296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shape and Enhancement Characteristics of Pancreatic Neuroendocrine Tumor on Preoperative Contrast-enhanced Computed Tomography May be Prognostic Indicators.
    Okabe H; Hashimoto D; Chikamoto A; Yoshida M; Taki K; Arima K; Imai K; Tamura Y; Ikeda O; Ishiko T; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Yamashita YI; Yoshizumi T; Beppu T; Yamashita Y; Baba H; Maehara Y
    Ann Surg Oncol; 2017 May; 24(5):1399-1405. PubMed ID: 27896509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptomeningeal metastases of a well-differentiated neuroendocrine tumour: a rare entity.
    Versluis JM; Brandsma D; van den Berg JG; Tesselaar M
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30391925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small Cystic Pancreatic Neuroendocrine Neoplasm with Huge Liver and Bone Metastases.
    Yasuda M; Takeda S; Lee M; Hoshi S; Hoshi T; Tanaka Y; Miyajima S; Takaya H; Kajimura K
    Intern Med; 2020; 59(23):3027-3032. PubMed ID: 33268697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration.
    Luersen GF; Wei W; Tamm EP; Bhosale PR; Szklaruk J
    J Comput Assist Tomogr; 2016; 40(5):717-22. PubMed ID: 27636124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.
    Tirosh A; Nilubol N; Patel D; Kebebew E
    Endocr Pract; 2018 Aug; 24(8):710-717. PubMed ID: 30084688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
    Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
    Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 35. Preoperative imaging and pathologic classification for pancreatic neuroendocrine tumors.
    Deguelte S; de Mestier L; Hentic O; Cros J; Lebtahi R; Hammel P; Kianmanesh R
    J Visc Surg; 2018 Apr; 155(2):117-125. PubMed ID: 29397338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Super-selective hepatic arterial infusions as established technique ('ARETAIEION' Protocol) of [177Lu]DOTA-TATE in inoperable neuroendocrine liver metastases of gastro-entero-pancreatic (GEP) tumors.
    Limouris GS; Karfis I; Chatzioannou A; Paphiti MI; Lyra M; Gennatas K; Nikou G; Voros D; Pragulidis GP; Polydorou AA; Gouliamos A
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):551-8. PubMed ID: 23358409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
    Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
    Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
    Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps.
    Ohki K; Igarashi T; Ashida H; Takenaga S; Shiraishi M; Nozawa Y; Ojiri H
    Jpn J Radiol; 2021 Jan; 39(1):66-75. PubMed ID: 32885378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
    De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
    World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.